ACME Laboratories (DHA:ACMELAB) 3-Year Revenue Growth Rate : 12.30% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is ACME Laboratories 3-Year Revenue Growth Rate?

ACME Laboratories's Revenue per Share for the three months ended in Mar. 2024 was BDT37.80.

During the past 12 months, ACME Laboratories's average Revenue per Share Growth Rate was 17.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 12.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 12.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 8 years, the highest 3-Year average Revenue per Share Growth Rate of ACME Laboratories was 13.50% per year. The lowest was 11.90% per year. And the median was 12.10% per year.

Competitive Comparison of ACME Laboratories's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, ACME Laboratories's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ACME Laboratories's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ACME Laboratories's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where ACME Laboratories's 3-Year Revenue Growth Rate falls into.

ACME Laboratories 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

ACME Laboratories (DHA:ACMELAB) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

ACME Laboratories 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of ACME Laboratories's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

ACME Laboratories (DHA:ACMELAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

N/A

Address

1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207

Website

https://www.acmeglobal.com

ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The company offers pharmaceutical, ayurvedic, herbal, nutraceutical products, and veterinary products. It produces various forms of dosage including tablet, capsule, dry syrup, cream, ointment, powder and injection among others.

ACME Laboratories (DHA:ACMELAB) Headlines

No Headlines